{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:49:19Z","timestamp":1790851759230,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1598,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007110","name":"Schering-Plough","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.jacc.2008.12.021","type":"journal-article","created":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T10:13:19Z","timestamp":1237371199000},"page":"1021-1030","source":"Crossref","is-referenced-by-count":107,"title":["Advanced Age, Antithrombotic Strategy, and Bleeding in Non\u2013ST-Segment Elevation Acute Coronary Syndromes"],"prefix":"10.1016","volume":"53","author":[{"given":"Renato D.","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen P.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven V.","family":"Manoukian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel E.","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Feit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey D.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Charles V.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Magnus","family":"Ohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2008.12.021_bib1","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jacc.2005.05.084","article-title":"Evolution in cardiovascular care for elderly patients with non\u2013ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative","volume":"46","author":"Alexander","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2008.12.021_bib2","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ahj.2007.03.035","article-title":"Interactions between heparins, glycoprotein IIb\/IIIa antagonists, and coronary intervention","volume":"153","author":"Brieger","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib3","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1161\/CIRCULATIONAHA.107.182615","volume":"115","author":"Alexander","year":"2007","journal-title":"Circulation"},{"issue":"Suppl E","key":"10.1016\/j.jacc.2008.12.021_bib4","first-page":"6E","article-title":"Antithrombotic treatment of acute coronary syndromes","volume":"14","author":"Th\u00e9roux","year":"1998","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2008.12.021_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.12.021_bib6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.12.021_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2008.12.021_bib8","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Clopidogrel for the Reduction of Events During Observation","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2008.12.021_bib9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jacc.2007.02.028","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2008.12.021_bib10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archinte.158.10.1113","article-title":"Elderly patients receive less aggressive medical and invasive management of unstable angina: potential impact of practice guidelines","volume":"158","author":"Giugliano","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2008.12.021_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1067\/mhj.2000.107172","article-title":"First report of an intravenous and oral glycoprotein IIb\/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trials","volume":"140","author":"Giugliano","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.292.13.1555","article-title":"Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes","volume":"292","author":"Rao","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2008.12.021_bib13","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.12.021_bib14","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial","volume":"49","author":"Manoukian","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2008.12.021_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehn358","article-title":"Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes","author":"Budaj","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib16","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1067\/mhj.2001.119374","article-title":"Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: final report reanalysis of the Bivalirudin Angioplasty Study","volume":"142","author":"Bittl","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2008.12.021_bib18","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.jacc.2005.12.077","article-title":"A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial","volume":"47","author":"Gibson","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2008.12.021_bib19","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.12.021_bib20","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.298.21.2497","article-title":"Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial","volume":"298","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2008.12.021_bib21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ahj.2004.04.036","article-title":"Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale","volume":"148","author":"Stone","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2008.12.021_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11239-007-0094-9","article-title":"Thrombotic preparedness in aging: a translatable construct for thrombophilias?","volume":"24","author":"Becker","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2008.12.021_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.0000082924.75945.48","article-title":"Aging, progenitor cell exhaustion, and atherosclerosis","volume":"108","author":"Rauscher","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.12.021_bib25","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1172\/JCI113238","article-title":"Aging-associated changes in indices of thrombin generation and protein C activation in humans","volume":"80","author":"Bauer","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2008.12.021_bib26","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1182\/blood.V85.11.3144.bloodjournal85113144","article-title":"Hypercoagulability in centenarians: the paradox of successful aging","volume":"85","author":"Mari","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2008.12.021_bib27","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jacc.2008.05.054","article-title":"Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel","volume":"52","author":"Ang","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2008.12.021_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ahj.2004.06.003","article-title":"Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE)","volume":"149","author":"Avezum","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib29","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"Excess dosing of antiplatelet and antithrombin agents in the treatment of non\u2013ST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2008.12.021_bib30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.12.021_bib31","first-page":"45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non\u2013ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2008.12.021_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jama.292.1.55","article-title":"Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non\u2013ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial","volume":"292","author":"Blazing","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2008.12.021_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11239-006-5708-0","article-title":"Low-molecular-weight heparin compared with unfractionated heparin for patients with non\u2013ST-segment elevation acute coronary syndromes treated with glycoprotein IIb\/IIIa inhibitors: results from the CRUSADE initiative","volume":"21","author":"Singh","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2008.12.021_bib34","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non\u2013Q-wave myocardial infarction: results of the TIMI 11B trial","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.12.021_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.96.1.61","article-title":"Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for six weeks in the management of unstable coronary artery disease","volume":"96","author":"Klein","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.12.021_bib36","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1053\/euhj.1999.1879","volume":"20","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib37","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ahj.2006.08.002","volume":"152","author":"White","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib38","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.ehj.2004.06.028","article-title":"Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial","volume":"25","author":"de Lemos","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib39","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/eurheartj\/ehn236","article-title":"Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial","volume":"29","author":"Lopes","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib40","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0002-8703(00)90018-8","article-title":"Age and outcome after acute coronary syndromes without persistent ST-segment elevation","volume":"139","author":"Hasdai","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib41","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Yusuf","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.12.021_bib42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-147-5-200709040-00005","article-title":"Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes","volume":"147","author":"Fox","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2008.12.021_bib43","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJMoa0802944","article-title":"Bivalirudin versus unfractionated heparin during percutaneous coronary intervention","volume":"359","author":"Kastrati","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.12.021_bib44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2008.03.023","article-title":"Unfractionated heparin dosing and risk of major bleeding in non\u2013ST-segment elevation acute coronary syndromes","volume":"156","author":"Melloni","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib45","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/archinte.167.14.1539","article-title":"Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes","volume":"167","author":"LaPointe","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2008.12.021_bib46","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-141-3-200408030-00007","article-title":"The effect of routine, early invasive management on outcome for elderly patient with non\u2013ST-segment elevation acute coronary syndromes","volume":"141","author":"Bach","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2008.12.021_bib47","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ahj.2005.03.039","article-title":"Age-related differences in the management and outcome of patients with acute coronary syndromes","volume":"151","author":"Yan","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ahj.2003.08.007","article-title":"Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction","volume":"147","author":"Mehta","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib49","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/eurheartj\/ehn124","article-title":"Management and 6-month outcomes in elderly and very elderly patients with high-risk non\u2013ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events","volume":"29","author":"Devlin","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2008.12.021_bib50","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0195-668X(03)00485-8","article-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Moscucci","year":"2003","journal-title":"Eur Heart J"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510970900031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510970900031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T06:16:06Z","timestamp":1656742566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510970900031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S073510970900031X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2008.12.021","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}